Par Pharmaceutical Companies, Inc. (NYSE:PRX)

CAPS Rating: 3 out of 5

The Company, through its subsidiary Par Pharmaceutical, Inc., is engaged in the development, manufacture and distribution of generic pharmaceuticals and branded pharmaceuticals in the United States.

Recs

0
Player Avatar pulpchamber (< 20) Submitted: 2/12/2010 5:05:49 PM : Outperform Start Price: $25.14 PRX Score: +41.26

Quality company with great growth!!

Featured Broker Partners


Advertisement